mCherry mRNA
mCherry reporter mRNA.

Browse the E&E BioClub catalogue by product category and application. Select any item to see its full description and enquire by catalog number.
Listed prices are shown in USD as formatted in the supplied product list. Contact us to confirm current availability and pricing.
mCherry reporter mRNA.

TurboGFP reporter mRNA.

EGFP mRNA.
Gaussia luciferase reporter mRNA.
Cypridina luciferase reporter mRNA.
Firefly luciferase reporter mRNA.
Genomic DNA of HEK293 cells.
Genomic DNA of Vero cells.
These catalog plasmids are off-the-shelf templates for modification or as starting material for further large-scale preparation. For purification of your own plasmid samples, see our plasmid preparation service.
DNA vector for in vitro transcription of mCherry mRNA, with a 208-bp polyA tail, HindIII restriction site, and T7 terminator.
For co-transcriptional cap analog incorporation, use CleanCap AG. For enzymatic capping by vaccinia capping enzymes or faustovirus capping enzyme, nucleotide A is not a suitable substrate under in vitro conditions. Contact us to request a different version.
DNA vector for in vitro transcription of TurboGFP mRNA, with a 208-bp polyA tail, HindIII restriction site, and T7 terminator.
For co-transcriptional cap analog incorporation, use CleanCap AG. For enzymatic capping by vaccinia capping enzymes or faustovirus capping enzyme, nucleotide A is not a suitable substrate under in vitro conditions. Contact us to request a different version.
DNA vector for in vitro transcription of a bicistronic mRNA encoding EGFP and Sleeping Beauty Transposase.
Monitor successful mRNA transfection and duration by the EGFP fluorescent signal; low SB Transposase expression mediated by IRES reduces removal events of the already transposed transgene from the genome. For co-transcriptional cap analog incorporation, use CleanCap AG. RNA produced with this vector is not suitable for in vitro enzymatic capping.
DNA vector for in vitro transcription of Cypridina luciferase mRNA, with a 208-bp polyA tail, HindIII restriction site, and T7 terminator.
For co-transcriptional cap analog incorporation, use CleanCap AG. For enzymatic capping by vaccinia capping enzymes or faustovirus capping enzyme, nucleotide A is not a suitable substrate under in vitro conditions. Contact us to request a different version.
DNA vector for in vitro transcription of Flippase mRNA, with a 208-bp polyA tail, HindIII restriction site, and T7 terminator.
For co-transcriptional cap analog incorporation, use CleanCap AG. For enzymatic capping by vaccinia capping enzymes or faustovirus capping enzyme, nucleotide A is not a suitable substrate under in vitro conditions. Contact us to request a different version.
DNA vector for in vitro transcription of Gaussia luciferase mRNA, with a 208-bp polyA tail, HindIII restriction site, and T7 terminator.
For co-transcriptional cap analog incorporation, use CleanCap AG. For enzymatic capping by vaccinia capping enzymes or faustovirus capping enzyme, nucleotide A is not a suitable substrate under in vitro conditions. Contact us to request a different version.
DNA vector for in vitro transcription of Firefly luciferase mRNA, with a 208-bp polyA tail, HindIII restriction site, and T7 terminator.
For co-transcriptional cap analog incorporation, use CleanCap AG. For enzymatic capping by vaccinia capping enzymes or faustovirus capping enzyme, nucleotide A is not a suitable substrate under in vitro conditions. Contact us to request a different version.
DNA vector for in vitro transcription of mCherry mRNA, with a 195-bp polyA tail, HindIII restriction site, and T7 terminator.
For co-transcriptional cap analog incorporation, use ARCA. RNA produced with this vector is suitable for enzymatic capping.
DNA vector for in vitro transcription of TurboGFP and puromycin resistance gene, with a 208-bp polyA tail, MluI restriction site, and T7 terminator.
For co-transcriptional cap analog incorporation, use ARCA. RNA produced with this vector is suitable for enzymatic capping.
DNA vector for expressing genomic RNA of a third-generation lentiviral vector encoding an mCherry reporter gene.
Lentiviral vector packaging helper vector expressing VSV-G.
Lentiviral vector packaging helper vector expressing rev.
Lentiviral vector packaging helper vector expressing Gag/Pol.
DNA construct for AAV2 with a CMV promoter and polyA signal flanked by AAV2 ITRs.
Helper vector for AAV2 packaging encoding AAV2 Rep and AAV2 Cap.
Helper plasmid for packaging AAV vectors, encoding Ad5 E2A and Ad5 E4.
DNA plasmid encoding the antigenomic RNA of VSV expressing an mCherry reporter gene.
The helper plasmid encodes the VSV L gene needed to rescue recombinant VSV.
The DNA plasmid encodes the VSV N, P, and L genes required to rescue recombinant VSV. These three genes are organized into a tricistronic mRNA. Translation of the N gene is cap-dependent, whereas translation of the P and L genes is initiated by distinct Internal Ribosome Entry Sites (IRESs).
The helper plasmid encodes the VSV N gene needed to rescue recombinant VSV.
The helper plasmid encodes the VSV P and L genes required to rescue recombinant VSV. P and L are encoded by a bicistronic mRNA.
DNA construct for genome integration of the gene of interest (GOI) via flippase. The vector contains the reporter gene turboGFP and the puromycin resistance gene as the selection marker, both driven by the RSV promoter and separated by the P2A self-cleavage peptide. The CAGG promoter controls GOI expression. The GOI encoded by this vector is the mCherry reporter gene. Genome integration requires a pre-established cell line with an engineered FRT site, such as C0601 (derived from Vero cells). We accept requests for custom engineering of other cell lines.
DNA construct for random genome integration of the gene of interest (GOI) using the Sleeping Beauty transposon. The vector contains the reporter gene turboGFP and the zeocin resistance gene as the selection marker, both driven by the RSV promoter and separated by an Internal Ribosome Entry Site (IRES).
AAVS1 donor vector for transgene integration by CRISPR, containing AAVS1 homologous arms.
The gene of interest can be cloned downstream of the CAGG promoter.
DNA vector for engineering cell lines with an FRT site. The vector contains two Inverted Terminal Repeats of the Sleeping Beauty transposon, which mediates genome integration. The selection marker is TurboGFP and Zeocin, flanked by two FRT sites. The selection marker can be removed by introducing flippase, leaving one FRT site available for flippase-mediated transgene integration.
DNA vector for self-amplifying RNA expressing turboGFP.
Enquire about this product ↗VSV expressing an mRNA reporter gene.
Engineered Vero cells with a specific Flp recognition target (FRT) site integrated into the genome.
An engineered Vero cell line that constitutively expresses PD-L1, TurboGFP, and a puromycin resistance gene. The reporter and puromycin resistance genes are flanked by Flippase FRT sites and can be excised by introducing Flippase.
Contact us with a catalog number or describe the product you have in mind.
Ask about a product ↗